Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-08-050141
Filing Date
2008-03-07
Accepted
2008-03-07 15:26:30
Documents
9
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 928486
2 SCHEDULE OF PARTIES TO INDEMNIFICATION AGREEMENT dex10101.htm EX-10.10.1 2481
3 SCHEDULE OF PARTIES TO EXECUTIVE EMPLOYMENT AGREEMENT. dex10211.htm EX-10.21.1 1486
4 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 2021
5 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 5634
6 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 5711
7 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 2218
8 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 2363
9 GRAPHIC g10665img001.jpg GRAPHIC 70078
  Complete submission text file 0001193125-08-050141.txt   1048602
Mailing Address 15295 ALTON PARKWAY IRVINE CA 92618
Business Address 15295 ALTON PARKWAY IRVINE CA 92618 949-788-6000
ISTA PHARMACEUTICALS INC (Filer) CIK: 0000930553 (see all company filings)

EIN.: 330511719 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-31255 | Film No.: 08674068
SIC: 2835 In Vitro & In Vivo Diagnostic Substances